2025年人工智慧（AI）赋能的临床试验场地可行性全球市场报告

近年来，人工智慧（AI）赋能的临床试验场地可行性市场规模呈指数级增长，从2024年的12.4亿美元增长到2025年的15.3亿美元，复合年增长率达23.8%。这段历史性成长时期主要受以下因素驱动：人工智慧在临床研究中的应用日益广泛、对更快招募患者的需求不断增长、分散式临床试验的扩展、电子数据采集系统的进步以及监管机构对创新试验设计的支持。

预计未来几年，人工智慧 (AI) 赋能的临床试验中心可行性评估市场将呈指数级增长，到 2029 年市场规模将达到 35.5 亿美元，复合年增长率 (CAGR) 为 23.4%。预测期内的成长预计将受到以下因素的驱动：真实世界数据与 AI 分析的整合、虚拟临床试验平台的扩展、精准医疗投资的增加、预测模型在中心选择中的应用，以及 AI 赋能的自适应试验设计的开发。预测期内的关键趋势包括：利用预测分析优化中心选择、整合真实世界数据以增强可行性评估、部署机器学习演算法以预测患者招募、采用云端基础的AI 平台进行协作式试验规划，以及应用自然语言处理技术评估中心绩效数据。

由于市场参与企业对改善临床试验地点选择和招募的需求不断增长，临床试验数量的增加正在推动市场扩张。预计临床试验数量的成长将推动人工智慧驱动的临床试验地点可行性评估市场的发展。临床试验是在全球范围内进行的研究，旨在评估新疗法、药物和医疗器材的安全性和有效性。临床试验数量的增长主要归功于生物医学研发资金的增加，因为公共和私营部门都认识到迫切需要创新的医疗保健解决方案。临床试验的扩展正在推动对人工智慧驱动的可行性评估工具的需求。研究机构需要先进的系统来确定最佳地点、评估试验地点的性能并预测招募成功率。例如，英国製药工业协会在2023年11月报告称，英国启动的产业赞助临床试验数量增加了4.3%，从2021年的394项增加到2022年的411项。因此，临床试验数量的增加正在推动对人工智慧驱动的临床试验地点可行性评估解决方案的需求。

在人工智慧 (AI) 赋能的临床试验中心可行性评估市场中，主要公司正致力于开发先进工具，例如基于 AI 的可行性评估和招募平台，以优化临床试验中心的选择并简化临床试验流程。这些平台利用 AI 和机器学习技术评估临床实验和临床实验数据，透过临床实验的受试者匹配，实现更准确的中心识别和更有效的患者招募。这缩短了临床试验週期，并提高了试验成功率。例如，总部位于美国的综合性研究和技术服务公司 ObjectiveHealth 于 2023 年 6 月推出了 AI 平台 ObjectiveScreen。 ObjectiveScreen 透过增强病患辨识、预审和保留，改善临床试验结果。透过直接连接电子健康记录并应用机器学习演算法，ObjectiveScreen 可以识别高风险患者，并将他们配对到合适的临床试验中。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球范围内人工智慧（AI）赋能的临床试验中心的可行性：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 终端用户产业分析
• 全球人工智慧（AI）赋能的临床试验场地可行性市场：成长率分析
• 全球人工智慧（AI）赋能的临床试验场地可行性市场表现：规模与成长，2019-2024年
• 全球人工智慧（AI）赋能的临床试验场地可行性市场预测：规模与成长，2024-2029年，2034年
• 全球人工智慧（AI）驱动的临床实验中心可行性：潜在市场规模（TAM）

第六章 市场细分

• 全球人工智慧（AI）赋能的临床试验场地可行性市场（按组成部分划分）、实际结果和预测（2019-2024年、2024-2029年、2034年）
• 软体
• 服务
• 全球人工智慧（AI）赋能的临床试验场地可行性市场：按部署模式、性能和预测划分，2019-2024年、2024-2029年、2034年
• 云端基础的
• 本地部署
• 全球人工智慧（AI）赋能的临床试验场地可行性市场：按应用、性能和预测划分，2019-2024年、2024-2029年、2034年
• 位置选择
• 病患招募
• 通讯协定设计
• 绩效分析
• 其他用途
• 全球人工智慧（AI）赋能的临床试验场地可行性市场（按最终用户划分）：实际结果和预测（2019-2024年、2024-2029年、2034年）
• 製药公司
• 受託研究机构
• 学术研究机构
• 医院
• 其他最终用户
• 全球人工智慧（AI）赋能的临床试验场地可行性市场：细分软体、按类型划分、实际结果和预测（2019-2024年、2024-2029年、2034年）
• 预测分析软体
• 机器学习（ML）平台
• 自然语言处理（NLP）工具
• 数据视觉化软体
• 临床试验管理系统 (CTMS) 整合软体
• 真实世界数据（RWD）分析软体
• 基于风险的监控（RBM）软体
• 全球人工智慧（AI）赋能的临床试验场地可行性市场：按服务、类型、实际结果和预测进行细分，2019-2024年、2024-2029年、2034年
• 可行性评估服务
• 选址服务
• 病患招募支援服务
• 资料管理和分析服务
• 通讯协定优化服务
• 监理合规支援服务
• 咨询和顾问服务

第七章 区域和国家分析

• 全球人工智慧（AI）赋能的临床试验场地可行性市场：按地区划分，实际结果和预测，2019-2024年、2024-2029年、2034年
• 全球人工智慧（AI）赋能的临床试验场地可行性市场（按国家/地区划分）：实际结果和预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

• 人工智慧（AI）赋能的临床试验场地可行性市场：竞争格局
• 人工智慧（AI）赋能的临床试验场地可行性市场：公司概况
  • Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Dassault Systemes SE
• Parexel International Corporation
• ZS Associates Inc.
• Veeva Systems Inc.
• Verily Life Sciences LLC
• Signant Health Holding Corp.
• Saama Technologies LLC
• Elligo Health Research Inc.
• ConcertAI Inc.
• Medable Inc.
• Science 37 Inc.
• Castor EDC Inc.
• Unlearn.AI Inc.
• Antidote Technologies Inc.
• Deep 6 AI

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

• 2029年人工智慧（AI）赋能的临床试验场地可行性市场：提供新机会的国家
• 2029年人工智慧（AI）赋能的临床试验场地可行性市场：提供新机会的细分领域
• 2029年人工智慧（AI）赋能的临床试验场地可行性市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章附录

Artificial intelligence (AI)-powered clinical trial site feasibility refers to platforms and services that use advanced algorithms to assess and identify the most suitable clinical trial sites. These solutions process large datasets to forecast site performance and patient recruitment potential. They improve the speed and accuracy of decision-making, reduce the likelihood of trial delays, and streamline feasibility assessments while enhancing overall operational efficiency.

The primary component types of AI-powered clinical trial site feasibility are software and services. Software consists of AI-driven platforms and tools that evaluate trial data, site performance, and patient demographics to optimize site selection and feasibility. Deployment options include cloud-based and on-premises models, supporting applications such as site selection, patient recruitment, protocol design, performance analytics, and more. Key end-users include pharmaceutical companies, contract research organizations, academic research institutes, hospitals, and other healthcare entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI)-powered clinical trial site feasibility market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-powered clinical trial site feasibility market statistics, including artificial intelligence (AI)-powered clinical trial site feasibility industry global market size, regional shares, competitors with a artificial intelligence (AI)-powered clinical trial site feasibility market share, detailed artificial intelligence (AI)-powered clinical trial site feasibility market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered clinical trial site feasibility industry. The artificial intelligence (AI)-powered clinical trial site feasibility market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI)-powered clinical trial site feasibility market size has grown exponentially in recent years. It will grow from $1.24 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 23.8%. Growth during the historic period was driven by the rising adoption of AI in clinical research, increasing demand for faster patient recruitment, expansion of decentralized clinical trials, advancements in electronic data capture systems, and regulatory support for innovative trial designs.

The artificial intelligence (AI)-powered clinical trial site feasibility market size is expected to see exponential growth in the next few years. It will grow to $3.55 billion in 2029 at a compound annual growth rate (CAGR) of 23.4%. Growth in the forecast period is expected to be fueled by the integration of real-world data with AI analytics, expansion of virtual clinical trial platforms, rising investment in precision medicine, adoption of predictive modeling for site selection, and development of adaptive trial designs powered by AI. Key trends anticipated for the forecast period include the use of predictive analytics to optimize site selection, integration of real-world data to strengthen feasibility assessments, deployment of machine learning algorithms to forecast patient recruitment, adoption of cloud-based AI platforms for collaborative trial planning, and application of natural language processing to evaluate site performance data.

The increase in clinical trials is contributing to the expansion of the market due to rising demand for improved trial site selection and participant enrollment. The anticipated growth in clinical trials is expected to drive the artificial intelligence powered clinical trial site feasibility market in the future. Clinical trials are research studies conducted worldwide to evaluate the safety and effectiveness of new medical treatments, drugs, and devices. This rise in clinical trials is largely the result of increased funding in biomedical research and development, as both public and private sectors acknowledge the urgent need for innovative healthcare solutions. The expansion of clinical trials fuels the need for artificial intelligence powered feasibility tools, as research organizations require advanced systems to identify the most suitable locations, evaluate site performance, and estimate enrollment success. For example, in November 2023, the Association of the British Pharmaceutical Industry reported that the number of industry-sponsored clinical trials initiated in the United Kingdom grew by 4.3 percent, increasing from 394 trials in 2021 to 411 in 2022. As a result, the growing number of clinical trials is driving the demand for artificial intelligence powered clinical trial site feasibility solutions.

Key companies operating in the artificial intelligence powered clinical trial site feasibility market are concentrating on the development of advanced tools such as artificial intelligence based feasibility and recruitment platforms to enhance site selection and streamline operations within clinical trials. These platforms use artificial intelligence and machine learning technologies to evaluate trial protocols and site data, allowing for better identification of clinical sites and more effective patient recruitment through accurate participant matching. This accelerates trial timelines and increases the chances of success. For example, in June 2023, ObjectiveHealth, a company based in the United States that offers integrated research and technology services, introduced ObjectiveScreen, a platform powered by artificial intelligence that improves clinical trial outcomes by enhancing patient identification, prequalification, and retention. It connects directly with electronic health records and applies machine learning algorithms to identify high-risk individuals and match them with appropriate trials, thereby speeding up recruitment and improving overall trial performance.

In February 2023, ZS Associates, a United States based technology and consulting firm, acquired Trials.ai for an undisclosed amount. This acquisition aims to strengthen ZS Associates' role in the healthcare industry by enhancing the efficiency of clinical trials, shortening the time required to bring therapies to market, and improving the experience of trial participants. Trials.ai is a United States based company focused on healthcare that provides artificial intelligence and analytics solutions to support and improve clinical trial site feasibility.

Major players in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systemes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI.

North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-powered clinical trial site feasibility report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-powered clinical trial site feasibility market includes revenues earned by providing services such as site identification and selection, predictive enrollment modeling, investigator performance analysis, risk assessment and mitigation, and patient population analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-powered clinical trial site feasibility market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-powered clinical trial site feasibility ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-powered clinical trial site feasibility market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Services
• 2) By Deployment Mode: Cloud-Based; On-Premises
• 3) By Application: Site Selection; Patient Recruitment; Protocol Design; Performance Analytics; Other Applications
• 4) By End-User: Pharmaceutical Companies; Contract Research Organizations; Academic Research Institutes; Hospitals; Other End-Users
• Subsegments:
• 1) By Software: Predictive Analytics Software; Machine Learning (ML) Platforms; Natural Language Processing (NLP) Tools; Data Visualization Software; Clinical Trial Management System (CTMS) Integration Software; Real-World Data (RWD) Analytics Software; Risk-Based Monitoring (RBM) Software
• 2) By Services: Feasibility Assessment Services; Site Selection Services; Patient Recruitment Support Services; Data Management And Analytics Services; Protocol Optimization Services; Regulatory Compliance Support Services; Consulting And Advisory Services
• Companies Mentioned: Oracle Corporation; Thermo Fisher Scientific Inc.; NVIDIA Corporation; IQVIA Holdings Inc.; Labcorp Holdings Inc.; Dassault Systemes SE; Parexel International Corporation; ZS Associates Inc.; Veeva Systems Inc.; Verily Life Sciences LLC; Signant Health Holding Corp.; Saama Technologies LLC; Elligo Health Research Inc.; ConcertAI Inc.; Medable Inc.; Science 37 Inc.; Castor EDC Inc.; Unlearn.AI Inc.; Antidote Technologies Inc.; Deep 6 AI
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Characteristics

3. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Trends And Strategies

4. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Segmentation

• 6.1. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Services
• 6.2. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based
• On-Premises
• 6.3. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Site Selection
• Patient Recruitment
• Protocol Design
• Performance Analytics
• Other Applications
• 6.4. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Contract Research Organizations
• Academic Research Institutes
• Hospitals
• Other End-Users
• 6.5. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Analytics Software
• Machine Learning (ML) Platforms
• Natural Language Processing (NLP) Tools
• Data Visualization Software
• Clinical Trial Management System (CTMS) Integration Software
• Real-World Data (RWD) Analytics Software
• Risk-Based Monitoring (RBM) Software
• 6.6. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Feasibility Assessment Services
• Site Selection Services
• Patient Recruitment Support Services
• Data Management And Analytics Services
• Protocol Optimization Services
• Regulatory Compliance Support Services
• Consulting And Advisory Services

7. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 8.1. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 9.1. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 9.2. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 10.1. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 11.1. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 11.2. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 12.1. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 13.1. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 14.1. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 14.2. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 15.1. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 15.2. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 16.1. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 17.1. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 18.1. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 19.1. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 20.1. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 21.1. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 21.2. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 22.1. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 23.1. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 23.2. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 24.1. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 24.2. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 25.1. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 25.2. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 26.1. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 26.2. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 27.1. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 28.1. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 28.2. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 29.1. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 29.2. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Competitive Landscape
• 30.2. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Company Profiles
  • 30.2.1. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Other Major And Innovative Companies

• 31.1. Dassault Systemes SE
• 31.2. Parexel International Corporation
• 31.3. ZS Associates Inc.
• 31.4. Veeva Systems Inc.
• 31.5. Verily Life Sciences LLC
• 31.6. Signant Health Holding Corp.
• 31.7. Saama Technologies LLC
• 31.8. Elligo Health Research Inc.
• 31.9. ConcertAI Inc.
• 31.10. Medable Inc.
• 31.11. Science 37 Inc.
• 31.12. Castor EDC Inc.
• 31.13. Unlearn.AI Inc.
• 31.14. Antidote Technologies Inc.
• 31.15. Deep 6 AI

32. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

34. Recent Developments In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

35. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer